Archives

Spectrm: No-Code Conversational Marketing Automation Platform Closes $6.5 Million

By Noah Long ● Jun 28, 2023

Spectrm - a conversational marketing platform businesses use to automate one-to-one conversations with consumers on social messaging channels - announced a $6.5 million funding round. This funding round was led by 3TS Capital Partners with participation from existing investors including LHV Global, BDMI, North Base Media, and Jens Schumann.

Vertos Medical: $26 Million Closed To Develop Minimally Invasive Treatments For Lumbar Spinal Stenosis

By Annie Baker ● Jun 28, 2023

Vertos Medical - a leader in the development of innovative, minimally invasive treatments for lumbar spinal stenosis (LSS) - recently announced that it has raised $26 million in an oversubscribed Series C equity funding round. The financing was led by new investor Norwest Venture Partners with participation from existing investors including Pitango Venture Capital.

Cemex Ventures Kicks Off Construction Startup Competition 2023 With July 2 Deadline

By Amit Chowdhry ● Jun 27, 2023

Cemex Ventures - Cemex’s corporate venture capital (CVC) and open innovation unit - announced it has kicked off its Construction Startup Competition 2023, which is the largest competition in the construction industry for startups. And Cemex Ventures is joined in its 7th Competition edition by prominent leaders like Black & Veatch, Dysruptek by Haskell, Ferrovial, Hilti, VINCI Group’s Leonard, NOVA by Saint-Gobain, Trimble and Trimble Ventures, and Zacua Ventures.

ZapScale: Customer Success Platform Company Closes $2.5 Million

By Noah Long ● Jun 27, 2023

ZapScale - a trailblazer in delivering the easiest Customer Success Platform - recently announced that it has successfully raised $2.5 million in seed funding from leading venture capital firms, including Blume Ventures, Veda VC, Java Capital, 100xEntreprenuers, T2D3 Capital, Arka Venture Labs, and other prominent investors.

Blackpoint Cyber: Advanced Cybersecurity Suite Company Secures $190 Million

By Annie Baker ● Jun 27, 2023

Blackpoint Cyber - a leading technology-focused cybersecurity company providing its advanced security suite via managed service providers (MSPs) - announced it has received a $190 million growth investment led by Bain Capital Tech Opportunities with participation from Accel. Bain Capital Tech Opportunities and Accel join existing investors including Adelphi Capital Partners, Telecom Ventures, Pelican Ventures, and WP Global Partners.

Hopewell Therapeutics: $25 Million To Develop Next Generation Of Tissue-Targeted Lipid Nanoparticles

By Noah Long ● Jun 27, 2023

Hopewell Therapeutics - a biotechnology company with a differentiated lipid nanoparticle platform harnessing unique ionizable lipid chemistry - announced a seed funding round of up to $25 million to support its operations and growth. This funding round will enable the company to advance the development of genomic medicines based on its differentiated ttLNP platform through both internal pipeline programs and external partnerships.

Carta Healthcare: $25 Million Raised To Improve Patient Care By Utilizing Clinical Data

By Annie Baker ● Jun 27, 2023

Carta Healthcare - a company whose mission is to improve patient care by harnessing the value of clinical data - announced the final closing of its $25 million series B financing, thanks to additional investments from leading health systems Memorial Hermann Health System and UnityPoint Health.

ALTR Launches Snowflake Native Format-Preserving Data Protection With Snowpark

By Amit Chowdhry ● Jun 27, 2023

ALTR - an innovator of automated data governance and data security solutions - announced at Snowflake’s annual user conference Snowflake Summit 2023 the expansion of its SaaS data access control and tokenization solution with Snowflake.

Delve Bio: $35 Million Secured For Commercialize Metagenomic Sequencing Platform For Infectious Disease Diagnosis

By Dan Anderson ● Jun 27, 2023

Delve Bio - a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases - recently announced that it debuted with $35 million in Series A financing led by Perceptive Xontogeny Venture Fund II (PXV Fund II) and joined by Section 32 and GV. The funding round will be used to commercialize the company’s mNGS-based infectious disease test – which was developed by world-renowned infectious disease experts at the University of California San Francisco (UCSF) Center for Next-Gen Precision Diagnostics – and advance a pipeline of next-generation tests.

Meta Reveals Quest+ VR Subscription For $7.99 Per Month

By Annie Baker ● Jun 27, 2023

Meta has announced the new Quest+ VR subscription service, which will make it easier to explore the Meta Quest catalog. For $7.99 USD per month or $59.99 USD annually (a savings of more than 37%), users get access to two hand-picked VR titles every month. And when you sign up now through July 31, you will get your first month for $1 USD.

Wolfspeed: $1.25 Billion Secured Note Financing Led By Apollo Credit Funds Received

By Dan Anderson ● Jun 27, 2023

Wolfspeed - a global leader in silicon carbide technology - announced a $1.25 billion secured note financing from an investment group led by Apollo with an accordion feature for up to an additional $750 million. This financing supports the company’s previously announced U.S. expansion efforts and is a significant step toward achieving the company’s $6.5 billion global capacity expansion plan.

Advantus Health Partners: $2.9 Billion Strategic Collaboration With Medline Announced

By Amit Chowdhry ● Jun 27, 2023

During a grand opening of Medline’s new distribution center in West Jefferson, Ohio, Advantus Health Partners President Dan Hurry spoke this week about the significance of Medline’s unique strategic relationship with Advantus - which will support the improvement of quality patient care and operating performance of Advantus’s growing client base of more than 200 hospitals, 1,700 sites of care and over 600 clinics in 46 states.

Insilico Medicine Completes First Dose In Patients In Phase II Clinical Trial For INS018_055

By Amit Chowdhry ● Jun 27, 2023

Insilico Medicine - a generative artificial intelligence (AI)-driven clinical-stage biotech company - announced that it has completed the first dose in patients in the Phase II clinical trial of INS018_055, which marks the world's first anti-fibrotic small molecule inhibitor discovered and designed by generative AI, initiating Phase II clinical trials for further evaluation.

Joyful Ventures: $23 Million Raised To Advance Sustainable Protein Market

By Amit Chowdhry ● Jun 27, 2023

Joyful Ventures announced the successful closing of $23 million of a $25 million fund, aimed at catalyzing the $1.5 trillion global animal protein industry towards sustainable, and regenerative food solutions.

Acryl Data: Data Management Platform Company Raises $21 Million

By Amit Chowdhry ● Jun 27, 2023

Acryl Data – the company driving the DataHub Project, the most widely-used open source data catalog – announced that it has secured $21 million in Series A funding led by Bhaskar Ghosh, Partner at 8VC, with participation from Ram Shriram, Founder, Sherpalo Ventures and Guillermo Rauch, Founder and CEO of Vercel. This funding round will be used to deepen investments in customer success, accelerate the development of its cloud offering and extend the vision of its product towards a control plane for data.

Databricks Buying MosaicML In $1.3 Billion: Details

By Amit Chowdhry ● Jun 27, 2023

Databricks recently announced it has entered into a definitive agreement to acquire MosaicML, a leading generative AI platform. Combined, Databricks and MosaicML is looking to make generative AI accessible for every organization, enabling them to build, own and secure generative AI models with their own data. The deal is valued at approximately $1.3 billion, inclusive of retention packages.

Highwood Emissions Management Raises $3 Million To Enable Energy Companies To Pursue Climate Change Goals

By Amit Chowdhry ● Jun 26, 2023

Highwood Emissions Management - announced it has secured $3 million in seed funding - led by Energy Capital Ventures (ECV) and supported by Veritec Ventures. This marks the first external funding Highwood has accepted, positioning the company for accelerated growth and innovation in the emissions management market.

ThoughtSpot Acquiring Mode Analytics For $200 Million: Details

By Amit Chowdhry ● Jun 26, 2023

ThoughtSpot - an AI-Powered Analytics company, today announced it has signed a definitive agreement to acquire Mode Analytics, which is a modern Business Intelligence (BI) platform that brings data teams and business teams together to drive impact - in a cash and equity deal valued at $200 million.

IBM Buying Apptio In $4.6 Billion Deal: Details

By Amit Chowdhry ● Jun 26, 2023

IBM announced that it has entered into a definitive agreement with Vista Equity Partners to buy Apptio, a leader in financial and operational IT management and optimization (FinOps) software, for $4.6 billion. The acquisition of Apptio is going to accelerate the advancement of IBM's IT automation capabilities and enable enterprise leaders to deliver enhanced business value across technology investments.

Flow Medical: University Of Chicago Medical Device Startup Raises $1 Million

By Amit Chowdhry ● Jun 26, 2023

University of Chicago company Flow Medical recently announced it raised $1 million from a medical device manufacturer and they are finalizing a product design. Flow Medical - which is creating a multi-function catheter for helping diagnose and treat venous thromboembolic disease - was founded by the University of Chicago researchers Jonathan Paul, associate professor of medicine, and Osmanuddin Ahmed, associate professor of radiology.

Outbound AI: $16 Million Raised To Advance Conversation AI For Healthcare

By Amit Chowdhry ● Jun 26, 2023

Outbound AI - a conversation AI platform built for healthcare - announced it raised $16 million in funding co-led by Madrona Venture Group and SpringRock Ventures. And the company recently emerged from stealth mode last year to a market hungry for solutions that improve both productivity and profitability. Also joining Outbound AI's seed financing are Epic Ventures, Ascend, Pack Ventures, Locke Capital, Tacoma Venture Fund, and KCRise Fund.

Luxury Fashion Gaming Company DREST Bags £15 Million In Funding

By Amit Chowdhry ● Jun 26, 2023

DREST - a mobile gaming company that opens up the often exclusive worlds of luxury fashion, beauty and lifestyle to everyone, everywhere - announced recently that it raised £15 million of funding to continue the genre defining development of its new product proposition DREST Game 2.0.

Upstream Bio: $200 Million Secured For Advancing Therapeutics For Allergic and Inflammatory Diseases

By Annie Baker ● Jun 26, 2023

Upstream Bio - a biotech company focused on inflammation - recently debuted with a $200 million Series A financing. The funding round will enable Upstream to advance the company’s lead program UPB-101, a clinical-stage monoclonal antibody targeting the TSLP receptor, and build a pipeline of assets to address immune-mediated diseases. The Series A funding round was led jointly by OrbiMed and Maruho Co., Ltd. with participation from Access Biotechnology, Decheng Capital, HBM Healthcare Investments, TCG X, Omega Funds, Samsara BioCapital, and Altshuler Shaham Provident Funds Ltd.

Temple Health Integrates AI-Based Medication Management Solutions In Its Epic EHR

By Annie Baker ● Jun 26, 2023

One of the problems in health systems has been issues with inefficient medication reconciliation processes and the lack of price transparency, which often leads to patients abandoning prescriptions at the pharmacy counter after being surprised by the costs. Health technology company DrFirst recently announced that the 900-bed Temple University Health System (Temple Health) is answering these challenges by integrating AI-powered medication history and real-time prescription benefit checking solutions into its Epic electronic health record (EHR) system.

Yuvo Health Closes $20.2 Million To Bring Quality Care To Underserved Communities

By Noah Long ● Jun 26, 2023

Yuvo Health - a leading technology-enabled administrative and managed-care solution for community health centers - announced it has raised an oversubscribed $20.2 million Series A round of financing.

Pomelo Care: Virtual Medical Practice Company Raises $33 Million

By Dan Anderson ● Jun 26, 2023

Pomelo Care - a virtual medical practice that improves maternal and newborn health outcomes - recently announced $33 million in Seed and Series A funding led by Andreessen Horowitz. This funding round will be used for driving Pomelo’s continued partnership expansion with major health plans, including several Medicaid-managed care organizations, employers, and leading academic medical centers on the front lines of the national maternal health crisis.

Maverick Protocol: $9 Million Secured For Developing An Efficient DeFi Infrastructure

By Amit Chowdhry ● Jun 26, 2023

Maverick Protocol - a decentralized finance (DeFi) infrastructure provider focused on increasing industry efficiency - recently announced a $9 million round of funding. This funding round was led by venture capital firm Founders Fund, with support from other renowned firms including Pantera Capital, Binance Labs, Coinbase Ventures, and Apollo Crypto.

DexCare: Patient Demand And Care Access Platform Company Closes $75 Million In Series C

By Amit Chowdhry ● Jun 24, 2023

DexCare - a leading patient demand and care access platform - recently announced the closing of its $75 million Series C funding round led by ICONIQ Growth.

Kate Therapeutics: Gene Therapy Company Raises $51 Million

By Noah Long ● Jun 24, 2023

Kate Therapeutics - a next-generation gene therapy company - recently emerged from stealth mode with a $51 million Series A financing co-led by founding investor Westlake Village BioPartners and Versant Ventures with participation from Osage University Partners and UF Innovate | Ventures. And the company has granted Astellas Pharma Inc. an exclusive, worldwide license to develop, manufacture and commercialize KT430 to treat X-linked myotubular myopathy (XLMTM), the details of which are described in a separate press release issued today.

Mozart Therapeutics: $25 Million Closed To Develop Disease-Modifying Therapies For Autoimmune And Inflammatory Diseases

By Annie Baker ● Jun 23, 2023

Mozart Therapeutics - a leading developer of CD8 Treg Modulators for the treatment of autoimmune and inflammatory diseases - announced it has raised $25 million from new investors in a Series A extension, bringing the total raise to $80 million. The funding will be used to advance the company's lead candidate, MTX-101, into first-in-human clinical trials and to support pipeline expansion.